Alvotech to Participate in Jefferies Healthcare Conference in New York, June 5-6, 2024

Company Overview - Alvotech is a biotech company focused on the development and manufacture of biosimilar medicines for patients worldwide [2] - The company aims to be a global leader in the biosimilar space by delivering high-quality, cost-effective products and services [2] - Alvotech's current pipeline includes eight biosimilar candidates targeting autoimmune disorders, eye disorders, osteoporosis, respiratory diseases, and cancer [2] Strategic Partnerships - Alvotech has established a network of strategic commercial partnerships to enhance its global reach and leverage local expertise [2] - Key commercial partners include Teva Pharmaceuticals, STADA Arzneimittel AG, Fuji Pharma Co., Ltd, and several others across various regions including the US, Europe, Japan, China, and parts of South America, Africa, and the Middle East [2] Upcoming Events - Alvotech will participate in the Jefferies Healthcare Conference in New York on June 5-6, 2024, where it will present and host investor and business meetings [1] - Anil Okay, Chief Business Officer, is scheduled to present on June 6, 2024, at 1:00 pm EDT, with a live audio webcast available on Alvotech's investor website [1]